Mapping the EORTC QLQ-C30 and QLQ-LC13 to the SF-6D utility index in patients with lung cancer using machine learning and traditional regression methods

Abstract Background Preference-based measures of health-related quality of life (HRQoL), such as the Short Form Six-Dimension (SF-6D) is essential for health economic evaluations. However, these measures are rarely included in clinical trials for lung cancer. This study aims to develop mapping algor...

Full description

Saved in:
Bibliographic Details
Main Authors: Longlin Jiang, Kexun Li, Simiao Lu, Zhou Hong, Yifang Wang, Qin Xie, Qin He, Sirui Wei, Aoru Zhou, Hong Kang, Xuefeng Leng, Qing Yang, Yan Miao
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Health and Quality of Life Outcomes
Subjects:
Online Access:https://doi.org/10.1186/s12955-025-02394-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849767293796483072
author Longlin Jiang
Kexun Li
Simiao Lu
Zhou Hong
Yifang Wang
Qin Xie
Qin He
Sirui Wei
Aoru Zhou
Hong Kang
Xuefeng Leng
Qing Yang
Yan Miao
author_facet Longlin Jiang
Kexun Li
Simiao Lu
Zhou Hong
Yifang Wang
Qin Xie
Qin He
Sirui Wei
Aoru Zhou
Hong Kang
Xuefeng Leng
Qing Yang
Yan Miao
author_sort Longlin Jiang
collection DOAJ
description Abstract Background Preference-based measures of health-related quality of life (HRQoL), such as the Short Form Six-Dimension (SF-6D) is essential for health economic evaluations. However, these measures are rarely included in clinical trials for lung cancer. This study aims to develop mapping algorithms to predict SF-6D health utility scores from the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC QLQ-C30) and Quality of Life Questionnaire-Lung Cancer 13 (QLQ-LC13). Method The study sample comprised a Chinese population with lung cancer (n = 625). Traditional regression techniques, including Ordinary Least Squares regression, Generalized Linear Model, as well as machine learning techniques, such as Gradient Boosting Tree, Support Vector Regression, Ridge Regression are used. Five-fold cross-validation was performed. The performance metrics used to evaluate the models including R 2 , root mean square error (RMSE),mean absolute error (MAE) and mean absolute percentage error (MAPE) were used to screen the optimal model. Results The mean and median of SF-6D health utility values were 0.774 (SD = 0.154) and 7.795, respectively. The model with the best mapping performance was the Ridge regression model Five-fold cross-validation (CV) results show that the Ridge regression model has the best mapping performance, the final prediction indexes are R 2   = 0.753, RMSE = 0.074, MAE = 0.057, MAPE = 8.169%. Conclusions This study developed an optimized mapping algorithm to predict the utility index from the QLQ-C30 QLQ-LC13 to the SF-6D. This algorithm offers provides an effective alternative for estimating SF-6D estimation when the preference-based health utility values are unavailable.
format Article
id doaj-art-929a737295b94c2aad8dff6263d1d58a
institution DOAJ
issn 1477-7525
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series Health and Quality of Life Outcomes
spelling doaj-art-929a737295b94c2aad8dff6263d1d58a2025-08-20T03:04:15ZengBMCHealth and Quality of Life Outcomes1477-75252025-07-0123111210.1186/s12955-025-02394-8Mapping the EORTC QLQ-C30 and QLQ-LC13 to the SF-6D utility index in patients with lung cancer using machine learning and traditional regression methodsLonglin Jiang0Kexun Li1Simiao Lu2Zhou Hong3Yifang Wang4Qin Xie5Qin He6Sirui Wei7Aoru Zhou8Hong Kang9Xuefeng Leng10Qing Yang11Yan Miao12Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of ChinaDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of ChinaDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of ChinaDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of ChinaDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of ChinaDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of ChinaDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of ChinaDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of ChinaDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of ChinaDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of ChinaDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of ChinaNursing department, Sichuan Clinical Research Center for Cancer. Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of ChinaDepartment of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of ChinaAbstract Background Preference-based measures of health-related quality of life (HRQoL), such as the Short Form Six-Dimension (SF-6D) is essential for health economic evaluations. However, these measures are rarely included in clinical trials for lung cancer. This study aims to develop mapping algorithms to predict SF-6D health utility scores from the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core (EORTC QLQ-C30) and Quality of Life Questionnaire-Lung Cancer 13 (QLQ-LC13). Method The study sample comprised a Chinese population with lung cancer (n = 625). Traditional regression techniques, including Ordinary Least Squares regression, Generalized Linear Model, as well as machine learning techniques, such as Gradient Boosting Tree, Support Vector Regression, Ridge Regression are used. Five-fold cross-validation was performed. The performance metrics used to evaluate the models including R 2 , root mean square error (RMSE),mean absolute error (MAE) and mean absolute percentage error (MAPE) were used to screen the optimal model. Results The mean and median of SF-6D health utility values were 0.774 (SD = 0.154) and 7.795, respectively. The model with the best mapping performance was the Ridge regression model Five-fold cross-validation (CV) results show that the Ridge regression model has the best mapping performance, the final prediction indexes are R 2   = 0.753, RMSE = 0.074, MAE = 0.057, MAPE = 8.169%. Conclusions This study developed an optimized mapping algorithm to predict the utility index from the QLQ-C30 QLQ-LC13 to the SF-6D. This algorithm offers provides an effective alternative for estimating SF-6D estimation when the preference-based health utility values are unavailable.https://doi.org/10.1186/s12955-025-02394-8Lung CancerQuality of lifeQLQ-C30QLQ-LC13MappingSF-6D
spellingShingle Longlin Jiang
Kexun Li
Simiao Lu
Zhou Hong
Yifang Wang
Qin Xie
Qin He
Sirui Wei
Aoru Zhou
Hong Kang
Xuefeng Leng
Qing Yang
Yan Miao
Mapping the EORTC QLQ-C30 and QLQ-LC13 to the SF-6D utility index in patients with lung cancer using machine learning and traditional regression methods
Health and Quality of Life Outcomes
Lung Cancer
Quality of life
QLQ-C30
QLQ-LC13
Mapping
SF-6D
title Mapping the EORTC QLQ-C30 and QLQ-LC13 to the SF-6D utility index in patients with lung cancer using machine learning and traditional regression methods
title_full Mapping the EORTC QLQ-C30 and QLQ-LC13 to the SF-6D utility index in patients with lung cancer using machine learning and traditional regression methods
title_fullStr Mapping the EORTC QLQ-C30 and QLQ-LC13 to the SF-6D utility index in patients with lung cancer using machine learning and traditional regression methods
title_full_unstemmed Mapping the EORTC QLQ-C30 and QLQ-LC13 to the SF-6D utility index in patients with lung cancer using machine learning and traditional regression methods
title_short Mapping the EORTC QLQ-C30 and QLQ-LC13 to the SF-6D utility index in patients with lung cancer using machine learning and traditional regression methods
title_sort mapping the eortc qlq c30 and qlq lc13 to the sf 6d utility index in patients with lung cancer using machine learning and traditional regression methods
topic Lung Cancer
Quality of life
QLQ-C30
QLQ-LC13
Mapping
SF-6D
url https://doi.org/10.1186/s12955-025-02394-8
work_keys_str_mv AT longlinjiang mappingtheeortcqlqc30andqlqlc13tothesf6dutilityindexinpatientswithlungcancerusingmachinelearningandtraditionalregressionmethods
AT kexunli mappingtheeortcqlqc30andqlqlc13tothesf6dutilityindexinpatientswithlungcancerusingmachinelearningandtraditionalregressionmethods
AT simiaolu mappingtheeortcqlqc30andqlqlc13tothesf6dutilityindexinpatientswithlungcancerusingmachinelearningandtraditionalregressionmethods
AT zhouhong mappingtheeortcqlqc30andqlqlc13tothesf6dutilityindexinpatientswithlungcancerusingmachinelearningandtraditionalregressionmethods
AT yifangwang mappingtheeortcqlqc30andqlqlc13tothesf6dutilityindexinpatientswithlungcancerusingmachinelearningandtraditionalregressionmethods
AT qinxie mappingtheeortcqlqc30andqlqlc13tothesf6dutilityindexinpatientswithlungcancerusingmachinelearningandtraditionalregressionmethods
AT qinhe mappingtheeortcqlqc30andqlqlc13tothesf6dutilityindexinpatientswithlungcancerusingmachinelearningandtraditionalregressionmethods
AT siruiwei mappingtheeortcqlqc30andqlqlc13tothesf6dutilityindexinpatientswithlungcancerusingmachinelearningandtraditionalregressionmethods
AT aoruzhou mappingtheeortcqlqc30andqlqlc13tothesf6dutilityindexinpatientswithlungcancerusingmachinelearningandtraditionalregressionmethods
AT hongkang mappingtheeortcqlqc30andqlqlc13tothesf6dutilityindexinpatientswithlungcancerusingmachinelearningandtraditionalregressionmethods
AT xuefengleng mappingtheeortcqlqc30andqlqlc13tothesf6dutilityindexinpatientswithlungcancerusingmachinelearningandtraditionalregressionmethods
AT qingyang mappingtheeortcqlqc30andqlqlc13tothesf6dutilityindexinpatientswithlungcancerusingmachinelearningandtraditionalregressionmethods
AT yanmiao mappingtheeortcqlqc30andqlqlc13tothesf6dutilityindexinpatientswithlungcancerusingmachinelearningandtraditionalregressionmethods